1. Virus-like particle vaccines: immunology and formulation for clinical translation
   Braeden Donaldson et al, 2018, Expert Review of Vaccines CrossRef
2. Serum level and single-nucleotide polymorphisms of toll-like receptor-7 among urinary bladder cancer Iraqi patients
   Rasha M. A. Al-Humairi et al, 2019, Egyptian Journal of Medical Human Genetics CrossRef
3. The antitumoral activity of TLR7 ligands is corrupted by the microenvironment of pancreatic tumors
   Marie Rouanet et al, 2022, Molecular Therapy CrossRef
4. Synergistic Chemo-Immunotherapy Using pH-Responsive Nanoparticles in Breast Cancer Treatment: In Vitro and In Vivo Studies
   Kavya Sree Maravajjala et al, 2024, Molecular Pharmaceutics CrossRef
5. TLR2 controls random motility, while TLR7 regulates chemotaxis of microglial cells via distinct pathways
   Masataka Ifuku et al, 2016, Brain, Behavior, and Immunity CrossRef
6. RETRACTED: Overexpression of microRNA-216a-3p Accelerates the Inflammatory Response in Cardiomyocytes in Type 2 Diabetes Mellitus by Targeting IFN-α2
   Xiaomeng Liu et al, 2020, Frontiers in Endocrinology CrossRef
7. Bidirectional expression of Toll-like receptor 7 gene in urinary bladder cancer and urinary tract infection of Iraqi patients
   Rasha M.A. Al-Humairi et al, 2019, Gene Reports CrossRef
8. Pharmacological activation of TLR7 exerts inhibition on the replication of EV-D68 in respiratory cells
   Huili Li et al, 2024, Journal of Virology CrossRef
9. Pancreatic Cancer and Immunotherapy: A Clinical Overview
   Florentine E. F. Timmer et al, 2021, Cancers CrossRef
10. Polydopamine–Mesoporous Silica Core–Shell Nanoparticles for Combined Photothermal Immunotherapy
    Anushree Seth et al, 2020, ACS Applied Materials & Interfaces CrossRef
11. Anti-tumor Activity of Toll-Like Receptor 7 Agonists
    Huju Chi et al, 2017, Frontiers in Pharmacology CrossRef
12. Agonist and antagonist ligands of toll-like receptors 7 and 8: Ingenious tools for therapeutic purposes
    Cindy Patinote et al, 2020, European Journal of Medicinal Chemistry CrossRef
13. Immunotherapy in Pancreatic Cancer
    Zachary P. Yeung et al, 2023, Pancreatic Cancer CrossRef
14. Exploration of the System-Level Mechanisms of the Herbal Drug FDY003 for Pancreatic Cancer Treatment: A Network Pharmacological Investigation
    Ho-Sung Lee et al, 2022, Evidence-Based Complementary and Alternative Medicine CrossRef
15. Toll-like receptor 7/8 agonist R848 alters the immune tumor microenvironment and enhances SBRT-induced antitumor efficacy in murine models of pancreatic cancer
    Jian Ye et al, 2022, Journal for ImmunoTherapy of Cancer CrossRef
16. The Role of Toll-like Receptors (TLRs) Mediated Inflammation in Pancreatic Cancer Pathophysiology
    Arturo Orlacchio et al, 2021, International Journal of Molecular Sciences CrossRef